Table of Content

1 Off-body Wearable Injectors Market Overview
1.1 Product Overview and Scope of Off-body Wearable Injectors
1.2 Off-body Wearable Injectors Segment by Type
1.2.1 Global Off-body Wearable Injectors Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Electronical Injectors
1.2.3 Mechanical Injectors
1.2.4 Others
1.3 Off-body Wearable Injectors Segment by Application
1.3.1 Off-body Wearable Injectors Sales Comparison by Application: (2021-2027)
1.3.2 Immuno-oncology
1.3.3 Diabetes
1.3.4 Cardiovascular Diseases
1.3.5 Other
1.4 Global Off-body Wearable Injectors Market Size Estimates and Forecasts
1.4.1 Global Off-body Wearable Injectors Revenue 2016-2027
1.4.2 Global Off-body Wearable Injectors Sales 2016-2027
1.4.3 Off-body Wearable Injectors Market Size by Region: 2016 Versus 2021 Versus 2027

2 Off-body Wearable Injectors Market Competition by Manufacturers
2.1 Global Off-body Wearable Injectors Sales Market Share by Manufacturers (2016-2021)
2.2 Global Off-body Wearable Injectors Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Off-body Wearable Injectors Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Off-body Wearable Injectors Manufacturing Sites, Area Served, Product Type
2.5 Off-body Wearable Injectors Market Competitive Situation and Trends
2.5.1 Off-body Wearable Injectors Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Off-body Wearable Injectors Players Market Share by Revenue
2.5.3 Global Off-body Wearable Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Off-body Wearable Injectors Retrospective Market Scenario by Region
3.1 Global Off-body Wearable Injectors Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Off-body Wearable Injectors Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Off-body Wearable Injectors Market Facts & Figures by Country
3.3.1 North America Off-body Wearable Injectors Sales by Country
3.3.2 North America Off-body Wearable Injectors Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Off-body Wearable Injectors Market Facts & Figures by Country
3.4.1 Europe Off-body Wearable Injectors Sales by Country
3.4.2 Europe Off-body Wearable Injectors Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Off-body Wearable Injectors Market Facts & Figures by Region
3.5.1 Asia Pacific Off-body Wearable Injectors Sales by Region
3.5.2 Asia Pacific Off-body Wearable Injectors Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Off-body Wearable Injectors Market Facts & Figures by Country
3.6.1 Latin America Off-body Wearable Injectors Sales by Country
3.6.2 Latin America Off-body Wearable Injectors Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Off-body Wearable Injectors Market Facts & Figures by Country
3.7.1 Middle East and Africa Off-body Wearable Injectors Sales by Country
3.7.2 Middle East and Africa Off-body Wearable Injectors Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Off-body Wearable Injectors Historic Market Analysis by Type
4.1 Global Off-body Wearable Injectors Sales Market Share by Type (2016-2021)
4.2 Global Off-body Wearable Injectors Revenue Market Share by Type (2016-2021)
4.3 Global Off-body Wearable Injectors Price by Type (2016-2021)

5 Global Off-body Wearable Injectors Historic Market Analysis by Application
5.1 Global Off-body Wearable Injectors Sales Market Share by Application (2016-2021)
5.2 Global Off-body Wearable Injectors Revenue Market Share by Application (2016-2021)
5.3 Global Off-body Wearable Injectors Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Becton, Dickinson and Company
6.1.1 Becton, Dickinson and Company Corporation Information
6.1.2 Becton, Dickinson and Company Description and Business Overview
6.1.3 Becton, Dickinson and Company Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Becton, Dickinson and Company Product Portfolio
6.1.5 Becton, Dickinson and Company Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Medtronic Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Johnson & Johnson Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Insulet Corporation
6.4.1 Insulet Corporation Corporation Information
6.4.2 Insulet Corporation Description and Business Overview
6.4.3 Insulet Corporation Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Insulet Corporation Product Portfolio
6.4.5 Insulet Corporation Recent Developments/Updates
6.5 Unilife Corporation
6.5.1 Unilife Corporation Corporation Information
6.5.2 Unilife Corporation Description and Business Overview
6.5.3 Unilife Corporation Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Unilife Corporation Product Portfolio
6.5.5 Unilife Corporation Recent Developments/Updates
6.6 Enable Injections
6.6.1 Enable Injections Corporation Information
6.6.2 Enable Injections Description and Business Overview
6.6.3 Enable Injections Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Enable Injections Product Portfolio
6.6.5 Enable Injections Recent Developments/Updates
6.7 SteadyMed
6.6.1 SteadyMed Corporation Information
6.6.2 SteadyMed Description and Business Overview
6.6.3 SteadyMed Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
6.4.4 SteadyMed Product Portfolio
6.7.5 SteadyMed Recent Developments/Updates
6.8 Ypsomed Group
6.8.1 Ypsomed Group Corporation Information
6.8.2 Ypsomed Group Description and Business Overview
6.8.3 Ypsomed Group Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Ypsomed Group Product Portfolio
6.8.5 Ypsomed Group Recent Developments/Updates
6.9 West Pharmaceutical Services
6.9.1 West Pharmaceutical Services Corporation Information
6.9.2 West Pharmaceutical Services Description and Business Overview
6.9.3 West Pharmaceutical Services Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
6.9.4 West Pharmaceutical Services Product Portfolio
6.9.5 West Pharmaceutical Services Recent Developments/Updates
6.10 Unilife
6.10.1 Unilife Corporation Information
6.10.2 Unilife Description and Business Overview
6.10.3 Unilife Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Unilife Product Portfolio
6.10.5 Unilife Recent Developments/Updates
6.11 CeQur
6.11.1 CeQur Corporation Information
6.11.2 CeQur Off-body Wearable Injectors Description and Business Overview
6.11.3 CeQur Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
6.11.4 CeQur Product Portfolio
6.11.5 CeQur Recent Developments/Updates
6.12 Sensile Medical
6.12.1 Sensile Medical Corporation Information
6.12.2 Sensile Medical Off-body Wearable Injectors Description and Business Overview
6.12.3 Sensile Medical Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Sensile Medical Product Portfolio
6.12.5 Sensile Medical Recent Developments/Updates
6.13 Roche
6.13.1 Roche Corporation Information
6.13.2 Roche Off-body Wearable Injectors Description and Business Overview
6.13.3 Roche Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Roche Product Portfolio
6.13.5 Roche Recent Developments/Updates
6.14 ScPharmaceuticals
6.14.1 ScPharmaceuticals Corporation Information
6.14.2 ScPharmaceuticals Off-body Wearable Injectors Description and Business Overview
6.14.3 ScPharmaceuticals Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
6.14.4 ScPharmaceuticals Product Portfolio
6.14.5 ScPharmaceuticals Recent Developments/Updates
6.15 SteadyMed
6.15.1 SteadyMed Corporation Information
6.15.2 SteadyMed Off-body Wearable Injectors Description and Business Overview
6.15.3 SteadyMed Off-body Wearable Injectors Sales, Revenue and Gross Margin (2016-2021)
6.15.4 SteadyMed Product Portfolio
6.15.5 SteadyMed Recent Developments/Updates

7 Off-body Wearable Injectors Manufacturing Cost Analysis
7.1 Off-body Wearable Injectors Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Off-body Wearable Injectors
7.4 Off-body Wearable Injectors Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Off-body Wearable Injectors Distributors List
8.3 Off-body Wearable Injectors Customers

9 Off-body Wearable Injectors Market Dynamics
9.1 Off-body Wearable Injectors Industry Trends
9.2 Off-body Wearable Injectors Growth Drivers
9.3 Off-body Wearable Injectors Market Challenges
9.4 Off-body Wearable Injectors Market Restraints

10 Global Market Forecast
10.1 Off-body Wearable Injectors Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Off-body Wearable Injectors by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Off-body Wearable Injectors by Type (2022-2027)
10.2 Off-body Wearable Injectors Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Off-body Wearable Injectors by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Off-body Wearable Injectors by Application (2022-2027)
10.3 Off-body Wearable Injectors Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Off-body Wearable Injectors by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Off-body Wearable Injectors by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Off-body Wearable Injectors Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Off-body Wearable Injectors Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Off-body Wearable Injectors Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Off-body Wearable Injectors Covered in This Study
Table 5. Global Off-body Wearable Injectors Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Off-body Wearable Injectors Sales Share by Manufacturers (2016-2021)
Table 7. Global Off-body Wearable Injectors Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Off-body Wearable Injectors Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Off-body Wearable Injectors Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Off-body Wearable Injectors Manufacturing Sites and Area Served
Table 11. Manufacturers Off-body Wearable Injectors Product Type
Table 12. Global Off-body Wearable Injectors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Off-body Wearable Injectors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Off-body Wearable Injectors as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Off-body Wearable Injectors Sales by Region (2016-2021) & (K Units)
Table 16. Global Off-body Wearable Injectors Sales Market Share by Region (2016-2021)
Table 17. Global Off-body Wearable Injectors Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Off-body Wearable Injectors Sales by Country (2016-2021) & (K Units)
Table 19. North America Off-body Wearable Injectors Sales Market Share by Country (2016-2021)
Table 20. North America Off-body Wearable Injectors Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Off-body Wearable Injectors Revenue Market Share by Country (2016-2021)
Table 22. Europe Off-body Wearable Injectors Sales by Country (2016-2021) & (K Units)
Table 23. Europe Off-body Wearable Injectors Sales Market Share by Country (2016-2021)
Table 24. Europe Off-body Wearable Injectors Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Off-body Wearable Injectors Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Off-body Wearable Injectors Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Off-body Wearable Injectors Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Off-body Wearable Injectors Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Off-body Wearable Injectors Revenue Market Share by Region (2016-2021)
Table 30. Latin America Off-body Wearable Injectors Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Off-body Wearable Injectors Sales Market Share by Country (2016-2021)
Table 32. Latin America Off-body Wearable Injectors Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Off-body Wearable Injectors Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Off-body Wearable Injectors Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Off-body Wearable Injectors Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Off-body Wearable Injectors Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Off-body Wearable Injectors Revenue Market Share by Country (2016-2021)
Table 38. Global Off-body Wearable Injectors Sales (K Units) by Type (2016-2021)
Table 39. Global Off-body Wearable Injectors Sales Market Share by Type (2016-2021)
Table 40. Global Off-body Wearable Injectors Revenue (Million US$) by Type (2016-2021)
Table 41. Global Off-body Wearable Injectors Revenue Share by Type (2016-2021)
Table 42. Global Off-body Wearable Injectors Price (US$/Unit) by Type (2016-2021)
Table 43. Global Off-body Wearable Injectors Sales (K Units) by Application (2016-2021)
Table 44. Global Off-body Wearable Injectors Sales Market Share by Application (2016-2021)
Table 45. Global Off-body Wearable Injectors Revenue (Million US$) by Application (2016-2021)
Table 46. Global Off-body Wearable Injectors Revenue Share by Application (2016-2021)
Table 47. Global Off-body Wearable Injectors Price (US$/Unit) by Application (2016-2021)
Table 48. Becton, Dickinson and Company Corporation Information
Table 49. Becton, Dickinson and Company Description and Business Overview
Table 50. Becton, Dickinson and Company Off-body Wearable Injectors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Becton, Dickinson and Company Off-body Wearable Injectors Product
Table 52. Becton, Dickinson and Company Recent Developments/Updates
Table 53. Medtronic Corporation Information
Table 54. Medtronic Description and Business Overview
Table 55. Medtronic Off-body Wearable Injectors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Medtronic Off-body Wearable Injectors Product
Table 57. Medtronic Recent Developments/Updates
Table 58. Johnson & Johnson Corporation Information
Table 59. Johnson & Johnson Description and Business Overview
Table 60. Johnson & Johnson Off-body Wearable Injectors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Johnson & Johnson Off-body Wearable Injectors Product
Table 62. Johnson & Johnson Recent Developments/Updates
Table 63. Insulet Corporation Corporation Information
Table 64. Insulet Corporation Description and Business Overview
Table 65. Insulet Corporation Off-body Wearable Injectors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Insulet Corporation Off-body Wearable Injectors Product
Table 67. Insulet Corporation Recent Developments/Updates
Table 68. Unilife Corporation Corporation Information
Table 69. Unilife Corporation Description and Business Overview
Table 70. Unilife Corporation Off-body Wearable Injectors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Unilife Corporation Off-body Wearable Injectors Product
Table 72. Unilife Corporation Recent Developments/Updates
Table 73. Enable Injections Corporation Information
Table 74. Enable Injections Description and Business Overview
Table 75. Enable Injections Off-body Wearable Injectors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Enable Injections Off-body Wearable Injectors Product
Table 77. Enable Injections Recent Developments/Updates
Table 78. SteadyMed Corporation Information
Table 79. SteadyMed Description and Business Overview
Table 80. SteadyMed Off-body Wearable Injectors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. SteadyMed Off-body Wearable Injectors Product
Table 82. SteadyMed Recent Developments/Updates
Table 83. Ypsomed Group Corporation Information
Table 84. Ypsomed Group Description and Business Overview
Table 85. Ypsomed Group Off-body Wearable Injectors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Ypsomed Group Off-body Wearable Injectors Product
Table 87. Ypsomed Group Recent Developments/Updates
Table 88. West Pharmaceutical Services Corporation Information
Table 89. West Pharmaceutical Services Description and Business Overview
Table 90. West Pharmaceutical Services Off-body Wearable Injectors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. West Pharmaceutical Services Off-body Wearable Injectors Product
Table 92. West Pharmaceutical Services Recent Developments/Updates
Table 93. Unilife Corporation Information
Table 94. Unilife Description and Business Overview
Table 95. Unilife Off-body Wearable Injectors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Unilife Off-body Wearable Injectors Product
Table 97. Unilife Recent Developments/Updates
Table 98. CeQur Corporation Information
Table 99. CeQur Description and Business Overview
Table 100. CeQur Off-body Wearable Injectors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. CeQur Off-body Wearable Injectors Product
Table 102. CeQur Recent Developments/Updates
Table 103. Sensile Medical Corporation Information
Table 104. Sensile Medical Description and Business Overview
Table 105. Sensile Medical Off-body Wearable Injectors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Sensile Medical Off-body Wearable Injectors Product
Table 107. Sensile Medical Recent Developments/Updates
Table 108. Roche Corporation Information
Table 109. Roche Description and Business Overview
Table 110. Roche Off-body Wearable Injectors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Roche Off-body Wearable Injectors Product
Table 112. Roche Recent Developments/Updates
Table 113. ScPharmaceuticals Corporation Information
Table 114. ScPharmaceuticals Description and Business Overview
Table 115. ScPharmaceuticals Off-body Wearable Injectors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. ScPharmaceuticals Off-body Wearable Injectors Product
Table 117. ScPharmaceuticals Recent Developments/Updates
Table 118. SteadyMed Corporation Information
Table 119. SteadyMed Description and Business Overview
Table 120. SteadyMed Off-body Wearable Injectors Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. SteadyMed Off-body Wearable Injectors Product
Table 122. SteadyMed Recent Developments/Updates
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Off-body Wearable Injectors Distributors List
Table 126. Off-body Wearable Injectors Customers List
Table 127. Off-body Wearable Injectors Market Trends
Table 128. Off-body Wearable Injectors Growth Drivers
Table 129. Off-body Wearable Injectors Market Restraints
Table 130. Global Off-body Wearable Injectors Sales Forecast by Type (2022-2027) & (K Units)
Table 131. Global Off-body Wearable Injectors Sales Market Share Forecast by Type (2022-2027)
Table 132. Global Off-body Wearable Injectors Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 133. Global Off-body Wearable Injectors Revenue Market Share Forecast by Type (2022-2027)
Table 134. Global Off-body Wearable Injectors Sales Forecast by Application (2022-2027) & (K Units)
Table 135. Global Off-body Wearable Injectors Sales Market Share Forecast by Application (2022-2027)
Table 136. Global Off-body Wearable Injectors Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 137. Global Off-body Wearable Injectors Revenue Market Share Forecast by Application (2022-2027)
Table 138. Global Off-body Wearable Injectors Sales Forecast by Region (2022-2027) & (K Units)
Table 139. Global Off-body Wearable Injectors Sales Market Share Forecast by Region (2022-2027)
Table 140. Global Off-body Wearable Injectors Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 141. Global Off-body Wearable Injectors Revenue Market Share Forecast by Region (2022-2027)
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Off-body Wearable Injectors
Figure 2. Global Off-body Wearable Injectors Market Share by Type in 2020 & 2027
Figure 3. Electronical Injectors Product Picture
Figure 4. Mechanical Injectors Product Picture
Figure 5. Others Product Picture
Figure 6. Global Off-body Wearable Injectors Market Share by Application in 2020 & 2027
Figure 7. Immuno-oncology
Figure 8. Diabetes
Figure 9. Cardiovascular Diseases
Figure 10. Other
Figure 11. Global Off-body Wearable Injectors Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Off-body Wearable Injectors Market Size 2016-2027 (US$ Million)
Figure 13. Global Off-body Wearable Injectors Sales 2016-2027 (K Units)
Figure 14. Global Off-body Wearable Injectors Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Off-body Wearable Injectors Sales Share by Manufacturers in 2020
Figure 16. Global Off-body Wearable Injectors Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Off-body Wearable Injectors Players: Market Share by Revenue in 2020
Figure 18. Off-body Wearable Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Off-body Wearable Injectors Sales Market Share by Region (2016-2021)
Figure 20. Global Off-body Wearable Injectors Sales Market Share by Region in 2020
Figure 21. Global Off-body Wearable Injectors Revenue Market Share by Region (2016-2021)
Figure 22. Global Off-body Wearable Injectors Revenue Market Share by Region in 2020
Figure 23. U.S. Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. UAE Off-body Wearable Injectors Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Off-body Wearable Injectors by Type (2016-2021)
Figure 48. Sales Market Share of Off-body Wearable Injectors by Application (2016-2021)
Figure 49. Sales Market Share of Off-body Wearable Injectors by Application in 2020
Figure 50. Revenue Share of Off-body Wearable Injectors by Application (2016-2021)
Figure 51. Revenue Share of Off-body Wearable Injectors by Application in 2020
Figure 52. Manufacturing Cost Structure of Off-body Wearable Injectors
Figure 53. Manufacturing Process Analysis of Off-body Wearable Injectors
Figure 54. Off-body Wearable Injectors Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed